Try our Advanced Search for more refined results
Health - September, 2007
165 articles
- Immucor Lays SEC, Shareholder Actions To Rest
- BMS, Apothecon Pay $515M To Settle Pricing Claims
- Asbestos Victims Want Quigley President Out
- Foreign Plaintiffs Tossed From Rhodia Securities Case
- Clinical Trial Patients Barely Protected By FDA: Study
- FDA Orders Halt To Unapproved Cough-Suppressants
- Planned Parenthood Stole Business Method: Suit
- Canada Upholds Viagra Patent Over Apotex' Protests
- DOJ Fights Veterans' Health Care Reform Suit
- Court Knocks Digene Down Again In HPV Suit
- Microsoft Ruling May Embolden Regulators: Experts
- Suit Against Isolagen, Underwriters Moves Forward
- Medtronic Vows To Appeal $226.3M Verdict
- PTO Erred In Nixing Takeda's Double-Patent: Judge
- Judge OKs Metabolife's Ch. 11 Liquidation Plan
- President Bush Signs Drug User Fee Bill
- Orthopedic Cos. Pay $311M To End Kickback Probe
- Congress Mulls Overtime For Home Workers
- Teva, Barr Win Transfer Of Aventis' Allegra Patent Suit
- Adams Respiratory Sues Perrigo Over Mucinex Patent
- Drug Makers Prevail In Hormone Replacement Suit
- AstraZeneca Asks For More Discovery Time
- FDA Warns Consumers About Pain Drug
- No Federal Jurisdiction For Zyprexa Suit: Montana
- Judge Hands Alaris More Money In Patent Suit
- Dietary Supplement Maker's Antitrust Suit Tossed
- Novartis Accused Of Forum Shopping In Lamisil Case
- Damages Back In Play In Pfizer Patent Suit
- Baxter Seeks To Add More Patents In Dialysis Suit
- Pharmacogenomics And The "Learned Intermediary"
- Punitive Damages Nixed In Accutane Suicide Case
- Supreme Court Agrees To Hear Rezulin Case
- Roche Fights To Protect Boniva Patent
- AMO Wins Summary Judgment In LASIK Patent Case
- Eli Lilly Pays $18M To Settle Contract Squabble
- Depomed Says Teva Unit Infringed Diabetes Patents
- Utah AG Sues Slew Of Drug Cos. Over AWPs
- AstraZeneca Wants Seroquel, Zyprexa Plaintiffs' Docs
- Becton Dickinson Balks At Discovery In Syringe MDL
- Barr Sued Over Chewable Contraceptive
- House Bill Would Strengthen Food Import Laws
- Cordis Cites Stent Risk But Still Loses Patent Fight
- Dutch Pension Fund Files Amended Suit Over Vioxx
- Guidant Fights Health-Care Providers' Appeal Attempt
- Dr. Reddy's Wants Clarinex Claims Trimmed
- Alza Makes Another Push For Data In Ditropan Case
- Pfizer Wins Appeal Over Neurontin
- Novartis Drops Patent Claims Against Ranbaxy
- FDA Defends Delays Over Vioxx Documents
- Accutane Trial To Begin Monday, As Planned
- Environmental Guns Take Shot At Air Fresheners
- AWP Counsel Asks Court To Kick Haviland Law Firm
- Red Cross Fights Off J&J Suit Over Famous Mark
- Biotech Expert Becomes Dechert IP Partner
- Auditors Get Slaps On Wrists Over NCFE
- House Approves FDA Drug User Fee Legislation
- Papers Sealed In Cigna Case Over Eating Disorders
- Actavis Claims Cancer Drug Patents Are Invalid
- Tyco Dismissed From Fluid Injector Patent Case
- FDA Updates Warning Labels On Blockbuster Drugs
- Defibrillators Could Fail, Recall Warns
- Applera, Agilent Settle Genetic Research Patent Spat
- University Fights MTI In Brain Aneurysm Patent Case
- FDA Claims Dirty Advertising Over P&G Sanitizer
- Bio-Rad Claims Infringment Of Microplate Patent
- Judge Greenlights Baycol Plaintiffs' Appeal
- Orexigen, Duke, Eisai Strike Foreign IP Deal
- Ex-Tenet Attorney Faces False Claims Charges
- Abbott Shoots Down Government Complaint
- Cordis Stent Case May Be Consolidated
- Bayer Seeks Stay In Tainted Blood Products Suit
- ICU Medical Prevails In IV Patent Dispute
- Encysive Wins Dismissal Of Securities Suit
- Roche Files Third Suit This Month Over Boniva ANDAs
- J&J Asks Court To Resurrect Claim Against Abbott
- Judge Dismisses Number Of Metabolife Suits
- New York Hits Merck With Another Vioxx Suit
- J&J, Angiotech Reach Accord Over Stent Patents
- Pfizer Moves To Toss More Cases From Bextra MDL
- Aredia Case Belongs In State Court: Magistrate Judge
- Certified Ortho-McNeil FLSA Class Expected To Swell
- Apotex Bid To Overturn Prilosec Decision Denied
- EU Court Nixes Akzo Nobel's Assertion Of Privilege
- Merck Balks At Class Bid In Fosamax Case
- Judge Nixes Glaxo's Bid To Strike Paxil Testimony
- Orion sues Wockhardt Over Parkinson's Drug
- UnitedHealth Fights Probe By Minnesota AG
- Full Steam Ahead For e-MedSoft Discovery: Plaintiffs
- Aventis To Face Whistleblower Claims Over Lovenox
- NuvaRing Plaintiffs Battle Organon Over Jurisdiction
- Improper Use Of Fentora Can Be Deadly: Cephalon VP
- Judge Rejects Lipodissolve Ban
- 211 Plaintiffs Will Join Suit Against Merck Over FLSA
- Sanofi Plaintiffs Challenge Employee Declarations
- Sandata Assails 'Preposterous' Bid For Sanctions
- Sans Injunction, Open Season For Generic Protonix
- ASC Resists Alza's Bid For Ditropan Data
- St. Vincent's Must Face Race Bias Claims: Judge
- Plaintiffs Deny Desire For Seal In Aredia Case
- Before Settling, Guidant Plaintiffs Consider Appeal
- Canadian Court Upholds Lipitor In Crystal Form
- AstraZeneca Backs Up Call To Toss Seroquel Claims
- CORRECTED: Judge Issues Ruling In Guidant Price Publishing Spat
- Judge Sends Two AWP Cases Home
- Two New Articles Add More Fuel To Avandia Fire
- Teva, Dr. Reddy's Settle Generic Zoloft Dispute
- Big Pharmas Cite Elevator Ruling To Boost Case
- Lawyers Debate If Bundling Is Ready For High Court
- Judge Tosses Some Claims In Merck Race Bias Suit
- Pfizer Faces Swelling MDL Over Bextra, Celebrex
- Hogan & Hartson Lures FDA Attorney
- Novo Nordisk Seeks To Halt Sanofi Insulin Pen
- Airborne Suit Moved To Federal Court
- Judge Mulls Plaintiffs' Bid To Alter Mirapex Suit
- Apotex Suffers Defeat In Acular Dispute
- Ramipril Patent Invalid Due To Obviousness: Court
- Hoffman-La Roche Sues Teva Over Osteoporosis Drug
- AstraZeneca, Plaintiffs Spar Over Seroquel Expert
- Steptoe Adds Veteran IP Partner
- Biovail Settles With BofA, Trader In Conspiracy Case
- Abbott, Feds Sound Off On AWP Ruling
- Judge Ready To Approve Metabolife's Ch. 11 Plan
- Judge OKs Settlement In Drug Securities Case
- Sanofi-Aventis Pays $190M To Settle Drug Price Case
- Abbott Fights Depositions Of Former Head Honchos
- Carecore Blasts Plaintiffs' Lack Of Documents
- Judge Blocks Sale Of Teva's Generic Famvir
- Becton, RTI Spar Over Syringe Patents, Competition
- Pfizer Seeks Dismissal Of Another Bextra Suit
- Glaxo Investors Vie For Lead Plaintiff Role
- Abbott Warns Of Faulty Glucose Monitors
- ImClone To Pay $65M To End Erbitux Suit
- Acacia Unit Targets Medical Tech Bigwigs
- Sanctions Urged In Celexa, Lexapro Case
- Judge Orders Plaintiffs To Respond In Accutane Case
- Seroquel Plaintiffs Object To Dismissal Conversions
- House Ushers In New Era With Patent Reform Act
- Eli Lilly Adds 9 Defendants To Strattera Suit
- UnitedHealth Unit Pays $20M To Settle With 37 States
- Eli Lilly Settles With Doctor Over Zyprexa Leaks
- Novartis Rebuffs Claims In Aredia Case
- Nationwide Class For Vioxx Suit Rejected
- Judge Orders Vioxx Plaintffs To File Separate Claims
- Enzo Appeals Loss In DNA Detection Patent Suit
- J&J Unit Wants ASC To Turn Over Ditropan Docs
- Glaxo Seeks To Bar Testimony In Paxil Case
- Par Calls Novartis' Lotrel Patent Unenforceable
- Judge OKs Insider Trading Settlement In Drug Case
- Pfizer Moves To Toss Fraud Claims In Mirapex Case
- Ninth Circuit Remands Royalty Dispute Over Zilactin
- Judge Allows Teva To Launch Generic Herpes Drug
- Lexapro Patent Upheld On Appeal
- Schering, Employees To Face Off Over Benefit Plan
- Ortho-McNeil Spars With Makers Of Ultracet Generic
- Switching Cholesterol Drugs May Be Fatal: Study
- AstraZeneca Seeks More Dismissals In Seroquel Case
- Allergan Sued Over Dry Eye Patent
- Judge Siphons Off Funds For Aredia Attorneys
- Dr. Reddy's Wants Teva's Coreg Claims Bounced
- McKenzie-Willamette Suffers Blow In Antitrust Dispute
- Radiologists Say Actions Were Not Anti-Competitive
- Whistleblower Suit To Proceed Against Alterra
- Bausch & Lomb Settles Suits Over Proposed Merger
- Pharmexa Loses Bid To Restore Broad Patent Claims
- Novartis Motion Is Wolf In Sheep's Clothing: Plaintiffs